USP Amlodipine, Valsartan, and Hydrochlorothiazide Tablets –Assay and Impurities-Amlodipine,Valsartan,Hydrochlorothiazide Standard solution-SST Chromatogram USP-Assay

LC Conditions
Column

Luna Omega 3 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea

Brand

Luna Omega

Part No

00F-4784-E0

Phase Name

C18

Elution Type

Gradient

Mobile Phase

A: 0.1% Orthophosphoric acid in water. (1 ml of Orthophosphoric acid in dissolved in 1000 ml of water. Filtered through 0.22µ Nylon filter. Mobile phase A: Acetonitrile: water and Phosphoric acid in ratio of 50:950:1 ml v/v/v.

B: 0.1% Orthophosphoric acid in water. (1 ml of Orthophosphoric acid in dissolved in 1000 ml of water. Filtered through 0.22µ Nylon filter. Mobile phase B: Acetonitrile: water and Phosphoric acid in ratio of 950:50:1 ml v/v/v.

Gradient Profile

Step No.

Time(min)

%A

%B

1

0

95

5

2

3

50

50

3

6

40

60

4

10

5

95

5

10.1

95

5

6

15

95

5

Flow Rate

1.50 mL/min

Temperature

40°C

System

Waters ACQUITY UPLC H-Class Waters ACQUITY UPLC H-Class

Detection

LC/UV (DAD, PDA) @ 210

Detection Info

Order Items Used in This Application

Luna Omega 3 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea
00F-4784-E0

Luna Omega 3 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea

View Product

  • 1. Hydrochlorothiazide
  • 2. Amlodipine
  • 3. Valsartan
-OEChem-06211003152D<br><br> 25 26  0     0  0  0  0  0  0999 V2000<br>    3.4030    1.2327    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0<br>    6.8950   -0.8020    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0<br>    3.4030   -0.7673    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0<br>    7.3849   -1.6737    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0<br>    6.3850   -1.6622    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0<br>    3.9030   -1.6333    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0<br>    2.9030    0.0987    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0<br>    7.8010   -0.2881    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0<br>    6.8950    1.2674    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0<br>    2.5369   -1.2673    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0<br>    6.0010   -0.2673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0<br>    6.0010    0.7327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0<br>    7.8010    0.7535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0<br>    5.1350   -0.7673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0<br>    4.2690   -0.2673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0<br>    5.1350    1.2327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0<br>    4.2690    0.7327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0<br>    8.4119    0.6474    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0<br>    8.0101    1.3372    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0<br>    5.1350   -1.3873    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0<br>    8.3368   -0.6002    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0<br>    6.8878    1.8873    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0<br>    5.1350    1.8527    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0<br>    2.0000   -0.9573    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0<br>    2.5369   -1.8873    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0<br>  1 17  1  0  0  0  0<br>  2  4  2  0  0  0  0<br>  2  5  2  0  0  0  0<br>  2  8  1  0  0  0  0<br>  2 11  1  0  0  0  0<br>  3  6  2  0  0  0  0<br>  3  7  2  0  0  0  0<br>  3 10  1  0  0  0  0<br>  3 15  1  0  0  0  0<br>  8 13  1  0  0  0  0<br>  8 21  1  0  0  0  0<br>  9 12  1  0  0  0  0<br>  9 13  1  0  0  0  0<br>  9 22  1  0  0  0  0<br> 10 24  1  0  0  0  0<br> 10 25  1  0  0  0  0<br> 11 12  1  0  0  0  0<br> 11 14  2  0  0  0  0<br> 12 16  2  0  0  0  0<br> 13 18  1  0  0  0  0<br> 13 19  1  0  0  0  0<br> 14 15  1  0  0  0  0<br> 14 20  1  0  0  0  0<br> 15 17  2  0  0  0  0<br> 16 17  1  0  0  0  0<br> 16 23  1  0  0  0  0<br>M  END
Compound Name

Hydrochlorothiazide

CID

3639

Molecular Formula

C7H8ClN3O4S2

Molecular Weight

297

No. Hydrogen Bond Acceptors

7

No. Hydrogen Bond Donors

3

Similar Applications

Reversed Phase

USP Amlodipine, Valsartan, and Hydrochlorothiazide Tablets –Assay and Impurities- Amlodipine, Valsartan, Hydrochlorothiazide Standard solution 6 replicated injection overlay staged chromatogram USP

Luna Omega 3 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea

28203

Reversed Phase

USP Amlodipine, Valsartan, and Hydrochlorothiazide Tablets –Assay and Impurities- Amlodipine,Valsartan,Hydrochlorothiazide Standard solution Chromatogram USP-Impurities

Luna Omega 3 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea

28202

Reversed Phase

USP Amlodipine, Valsartan, and Hydrochlorothiazide Tablets –Assay and Impurities- Amlodipine,Valsartan,Hydrochlorothiazide Sensitivity solution Chromatogram USP-Impurities

Luna Omega 3 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea

28201

Reversed Phase

USP Amlodipine, Valsartan, and Hydrochlorothiazide Tablets –Assay and Impurities- Amlodipine,Valsartan,Hydrochlorothiazide System suitability solution Chromatogram USP-Impurities

Luna Omega 3 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea

28200

USP Amlodipine, Valsartan, and Hydrochlorothiazide Tablets –Assay and Impurities- Amlodipine,Valsartan,Hydrochlorothiazide Standard solution Chromatogram USP-Impurities

28199

USP Amlodipine, Valsartan, and Hydrochlorothiazide Tablets –Assay and Impurities-Amlodipine,Valsartan,Hydrochlorothiazide Sensitivity solution Chromatogram USP-Impurities

28198

USP Amlodipine, Valsartan, and Hydrochlorothiazide Tablets –Assay and Impurities-Amlodipine,Valsartan,Hydrochlorothiazide System Suitability solution-SST Chromatogram USP-Impurities

28197

Reversed Phase

USP Amlodipine, Valsartan, and Hydrochlorothiazide Tablets –Assay and Impurities-Amlodipine,Valsartan,Hydrochlorothiazide Standard solution-SST Chromatogram USP-Assay

Luna Omega 3 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea

28196

USP Amlodipine, Valsartan, and Hydrochlorothiazide Tablets –Assay and Impurities-Amlodipine,Valsartan,Hydrochlorothiazide Standard solution-SST Chromatogram USP-Assay

28195

Reversed Phase

System Suitability Solution Hydrochlorothiazide Tablets - Luna Omega 5u C18 250x4.6mm- replicate injection staggered

Luna Omega 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea

26147

Reversed Phase

System Suitability Solution Hydrochlorothiazide Tablets - Luna Omega 5u C18 250x4.6mm- replicate injection overlay

Luna Omega 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea

26146

Reversed Phase

System Suitability Solution Hydrochlorothiazide Tablets - Luna Omega 5u C18 250x4.6mm

Luna Omega 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea

26145

Reversed Phase

System Suitability Solution Hydrochlorothiazide Tablets - Kinetex 5u C18 250x4.6mm- replicate injections stacked

Kinetex 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea

26131

Reversed Phase

System Suitability Solution Hydrochlorothiazide Tablets - Kinetex 5u C18 250x4.6mm

Kinetex 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea

26130

System Suitability Solution Hydrochlorothiazide Tablets - Symmetry 5um C18 250 x 4.6 mm-replicate injection overlay

26129

System Suitability Solution Hydrochlorothiazide Tablets - Symmetry 5um C18 250 x 4.6 mm

26128

Reversed Phase

System Suitability Solution Hydrochlorothiazide Tablets - Kinetex 5um C18 250 x 4.6 mm

Kinetex 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea

25879

System Suitability Solution Hydrochlorothiazide Tablets - Symmetry 5um C18 250 x 4.6 mm (overlay)

25878

Reversed Phase

Standard Solution Hydrochlorothiazide Tablets - Kinetex & Symmetry 5um C18 250 x 4.6

Kinetex 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea

25877